Farms.com Home   News

AFBF Applauds Opening of Dairy Margin Coverage

The American Farm Bureau Federation applauds the U.S. Department of Agriculture’s announcement today that the Dairy Margin Coverage program will begin enrollment following publication of the rule in the Federal Register next week.

The program will be retroactive to Jan. 1 of this year, and coverage will be available through December. AFBF previously sent a letter to Deputy Under Secretary Gloria Montaño Greene and Farm Service Agency Administrator Zach Ducheneaux urging them to open enrollment for the Dairy Margin Coverage program as soon as possible.

“AFBF is pleased that FSA listened to our concerns and will soon open enrollment for this critical farm safety net program,” said AFBF President Zippy Duvall. “Dairy farming comes with unique challenges, and vital farm bill programs like Dairy Margin Coverage help farmers weather the storm in tough times. Any further delay in opening the program could have challenged the resilience of many farms, especially the most vulnerable. We look forward to the speedy implementation of the DMC program and efficient processing of claims.”

Dairy Margin Coverage is a risk management tool offered through the farm bill that provides support to farmers when the price of milk falls below the cost of supplies. Implementation delays resulted from adjustments to the program made when the 2018 farm bill was extended, and necessary technical updates.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.